Principia Biopharma (PRNB) PT Raised to $66 at Stifel
Tweet
Share
E-mailGet Alerts PRNB Hot Sheet
Price: $100.05 --0%
Rating Summary:
4 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
4 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Stifel analyst Derek C. Archila raised the price target on Principia Biopharma (NASDAQ: PRNB) to $66.00 (from $51.00) while maintaining a Buy rating.
You May Also Be Interested In
- Stella International Holdings (1836:HK) (SLNLF) PT Lowered to HK$10 at Macquarie
- Palmer Square Capital BDC (PSBD) PT Lowered to $10.25 at BofA Securities
- Kuaishou Technology (1024:HK) PT Lowered to HK$27.60 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
